Clinical Trials Directory

Trials / Completed

CompletedNCT01099176

Effects of Hypolipemic Treatment on Adipokines

The Effects of 90-day Monotherapies With Atorvastatin, Fenofibrate and Combined Therapy With Atorvastatin and Fenofibrate on Lipid Profile, Fasting Plasma Glucose, Proinflammatory Cytokines and Adipokines

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
78 (actual)
Sponsor
Medical University of Silesia · Academic / Other
Sex
All
Age
35 Years – 64 Years
Healthy volunteers
Accepted

Summary

The study is planned to show whether monotherapies or combined hypolipemic therapy influence the fasting plasma glucose, serum adipokines (leptin, adiponectin, resistin) and proinflammatory cytokines (interleukin-6, TNF alpha) during 30 and 90 day course.

Conditions

Interventions

TypeNameDescription
DRUGTo compare monotherapies and combined therapy with each otherEach patient received two tablets per day. Time interval between pills - 12 hours. In monotherapies patients received one active tablet and one placebo, in combined treatment both pills were active and in placebo group patients taken two placebo tablets

Timeline

Start date
2008-05-01
Primary completion
2009-05-01
Completion
2009-09-01
First posted
2010-04-06
Last updated
2010-04-09

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT01099176. Inclusion in this directory is not an endorsement.